These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 22817976)

  • 1. A dual hyperthyroidism.
    Pishdad GR; Pishdad R; Pishdad P
    Lancet; 2012 Jul; 380(9838):306. PubMed ID: 22817976
    [No Abstract]   [Full Text] [Related]  

  • 2. Papillary cancer in a patient treated with radioiodine for Graves' hyperthyroidism. Case report and a review of the risk.
    Tomlinson C; Nowles KW; McDougall IR
    Clin Nucl Med; 1991 Oct; 16(10):729-31. PubMed ID: 1742925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Papillary thyroid carcinoma in cervical lymph nodes with vanished thyroid gland after ablation of Graves' disease by radioactive iodine.
    Hamdy O; Raafat S; Saleh GA; Atallah K; M Saleh M; Shebl AM; Hegazy MA
    Ann R Coll Surg Engl; 2019 May; 101(5):e122-e124. PubMed ID: 30854863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radioactive iodine 1311 (RAI) treatment. The nearest to the "magic bullet" but should always be preceded by a risk assessment, especially in the pediatric patient.
    Lubin E
    Pediatr Endocrinol Rev; 2011 Sep; 9(1):415-6. PubMed ID: 22783638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Visual vignette.
    Generoso JC; Hoang TD; Peterson B; Shwayhat AF
    Endocr Pract; 2015 May; 21(5):557. PubMed ID: 25716639
    [No Abstract]   [Full Text] [Related]  

  • 6. Papillary carcinoma of the thyroid seven years after I-131 therapy for Graves' disease.
    McDougall IR; Nelsen TS; Kempson RL
    Clin Nucl Med; 1981 Aug; 6(8):368-71. PubMed ID: 6894894
    [No Abstract]   [Full Text] [Related]  

  • 7. Thyroid carcinoma risk in patients with hyperthyroidism and role of preoperative cytology in diagnosis.
    Gul K; Di Ri Koc A; Ki Yak G; Ersoy PE; Ugras NS; Ozdemi D; Ersoy R; Cakir B
    Minerva Endocrinol; 2009 Dec; 34(4):281-8. PubMed ID: 20046157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The treatment of hyperthyroidism.
    Crile G
    World J Surg; 1978 May; 2(3):279-80. PubMed ID: 581319
    [No Abstract]   [Full Text] [Related]  

  • 9. Thyroid fine-needle aspiration biopsy: which lesions should be biopsied before 131I therapy?
    Listewnik MH; Birkenfeld B; Chosia M; Elbl B; Piwowarska-Bilska H; Zorga P; Niedziałkowska K
    Ann Acad Med Stetin; 2011; 57(1):54-8. PubMed ID: 22593992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toxic adenoma and papillary thyroid carcinoma in a patient with Graves' disease.
    Valenti TM; Macchia E; Pisa R; Bucalo ML; Russo V; Colletti I; Compagno V; Abbadi V; Donatelli M
    J Endocrinol Invest; 1999 Oct; 22(9):701-4. PubMed ID: 10595835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence of thyroid carcinoma in Graves' disease.
    Shapiro SJ; Friedman NB; Perzik SL; Catz B
    Cancer; 1970 Dec; 26(6):1261-70. PubMed ID: 5536634
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatment of hyperthyroidism with sodium I 131. Carcinoma of the thyroid after 20 years.
    Kreps EM; Kreps SM; Kreps SI
    JAMA; 1973 Nov; 226(7):774-5. PubMed ID: 4800630
    [No Abstract]   [Full Text] [Related]  

  • 13. Thyrotoxicosis due to metastatic papillary thyroid cancer in a patient with Graves' disease.
    Basaria S; Salvatori R
    J Endocrinol Invest; 2002; 25(7):639-42. PubMed ID: 12150341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Thyroid nodule in Basedow-Graves disease and thyroid cancer: experience in 6 patients].
    Piraino P; Sepúlveda A; Ibarra A; Michelsen H; Gac A; Pumarino H
    Rev Med Chil; 1995 Nov; 123(11):1402-8. PubMed ID: 8733284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early visualization of 99mTc-pertechnetate in metastatic thyroid cancer in a patient with Graves' disease.
    Carr HA; Temple TE; Staab EV
    J Nucl Med; 1971 Jan; 12(1):40-2. PubMed ID: 5107457
    [No Abstract]   [Full Text] [Related]  

  • 16. High radioactive iodine uptake despite a fully suppressed TSH in a patient with thyroid cancer.
    Stathatos N; Gaz R; Ross DS; Daniels GH
    J Clin Endocrinol Metab; 2011 Mar; 96(3):589. PubMed ID: 21378221
    [No Abstract]   [Full Text] [Related]  

  • 17. Mucoepidermoid carcinoma post-radioactive iodine treatment of papillary thyroid carcinoma: unique presentation and putative etiologic association.
    Saluja K; Butler RT; Pytynia KB; Zhao B; Karni RJ; Weber RS; El-Naggar AK
    Hum Pathol; 2017 Oct; 68():189-192. PubMed ID: 28499545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An autonomously functioning thyroid carcinoma associated with euthyroid Graves' disease.
    Michigishi T; Mizukami Y; Shuke N; Satake R; Noguchi M; Aburano T; Tonami N; Hisada K
    J Nucl Med; 1992 Nov; 33(11):2024-6. PubMed ID: 1432166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fine needle aspiration biopsy of the thyroid gland in patients with prior Graves' disease treated with radioactive iodine. Morphologic findings and potential pitfalls.
    Centeno BA; Szyfelbein WM; Daniels GH; Vickery AL
    Acta Cytol; 1996; 40(6):1189-97. PubMed ID: 8960027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Encapsulated insular carcinoma of the thyroid arising in graves' disease: report of a case and review of the literature.
    Foroughi F; Saadat N; Salehian MT
    Int J Surg Pathol; 2012 Dec; 20(6):636-9. PubMed ID: 22689614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.